This study successfully identified specific proteins related to iron metabolism/ferroptosis pathways, such as ERN1 and SLC11A1, which demonstrate significant diagnostic potential for NAFLD, with SLC11A1 potentially possessing greater diagnostic value as a biomarker. Here, SLC11A1 is linked to metabolic dysfunction-associated steatotic liver disease.